Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms

Clinical trial NCT06307093 · COMPLETED

Trial details

NCT number: NCT06307093
Sponsor: R-Pharm
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Skin Melanoma Squamous Non-small-cell Lung Cancer Head and Neck Squamous Cell Carcinoma

Start date: 2023-03-01
Primary completion: 2023-07-15
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.